Target intelligence / Profile preview

BEND7 divergent transcript (BEND7-DT)

Target
BEND7-DT
Molecular classification
Long non-coding RNA (lncRNA), Divergent transcript, Other (not a protein-coding gene, receptor, or enzyme)
01

Overview

BEND7 divergent transcript (BEND7-DT) is a non-coding RNA produced by divergent transcription from the BEND7 gene locus. Divergent transcription is a widespread genomic phenomenon that typically generates antisense long non-coding RNAs from protein-coding gene promoters and may be involved in fine-tuning gene expression, especially for developmental transcription factors[2][4]. BEND7-DT is not a protein, receptor, or enzyme, and does not have a known role as a drug/therapeutic target[3]. While the function of BEND7-DT is not well characterized, such transcripts sometimes participate in local regulatory effects at chromatin, including transcriptional control, epigenetic boundary formation, or modulation of transcription factor activity[1][2]. Currently, there is no evidence for involvement in drug action, disease, or biomarker utility; further research may clarify functional roles or clinical relevance.

02

Mechanism of action

Not applicable; as a non-coding transcript, it is not directly targeted by drugs.

03

Biological functions

Possible regulatory role at promoters of developmental transcription factors or chromatin organizationAssociated with transcriptional regulation through mechanisms related to bidirectional transcriptionPotential influence over epigenetic states, including chromatin boundary formation and transcription factor recruitment in its corresponding locus (inferred from related BEN domain proteins and divergent transcript studies)

Beyond the preview

Go deeper on BEND7 divergent transcript (BEND7-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BEND7 divergent transcript (BEND7-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call